Minghui Pharmaceutical (Hangzhou) Ltd
Minghui Pharmaceutical (Hangzhou) Ltd
Explore linked clinical trials.17 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors | Advanced Breast Cancer; Advanced Malignant Solid Tumor | Recruiting | Phase 2 | 2026-10-09 | NCT07130383 | |
| A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors | Advanced Malignant Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07126665 | |
| A Study of MHB118C Injection in Patients With Advanced Solid Tumors | Advanced Malignant Solid Tumor | Recruiting | Phase 1 | 2026-10-09 | NCT07045454 | |
| MHB018A Treatment in Patients With Active Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Active, not recruiting | Phase 3 | 2026-10-09 | NCT06989918 | |
| A Study of MHB046C Injection in Patients With Advanced Solid Tumors | Advanced Solid Cancer | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06985355 | |
| MHB018A Treatment in Patients With Chronic Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Active, not recruiting | Phase 3 | 2026-09-24 | NCT07257185 | |
| A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo | Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo | Recruiting | Phase 3 | 2026-08-11 | NCT07682506 | |
| Treatment of Chronic Thyroid Eye Disease With MHB018A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Not yet recruiting | Phase 3 | 2026-06-04 | NCT07622121 | |
| Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Not yet recruiting | Phase 3 | 2026-06-04 | NCT07622108 | |
| Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Not yet recruiting | Phase 3 | 2026-06-04 | NCT07620405 | |
| A Study of MHB009C in Patients With Advanced Solid Tumors | Advanced Malignant Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-04-13 | NCT07326488 | |
| A Study of MHB048C in Patients With Advanced Solid Tumors | Advanced Malignant Solid Tumor; mCRPC (Metastatic Castration-resistant Prostate Cancer) | Recruiting | Phase 1 / Phase 2 | 2026-04-09 | NCT07192120 | |
| A Study of MHB042C in Patients With Advanced Solid Tumors | Advanced Malignant Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-04-09 | NCT07192107 | |
| Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 3 | 2026-03-30 | NCT07262476 | |
| A Study of MHB039A for Advanced Solid Tumor | Advanced Solid Tumor | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-20 | NCT06345482 | |
| A Study of MHB036C for Advanced Solid Tumor | Advanced Solid Tumor | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-19 | NCT06373406 | |
| A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer | Advanced Lung Cancer | Recruiting | Phase 1 / Phase 2 | 2025-11-17 | NCT07229599 |